Other markers of fibrinolytic activity, such as plasmin-alpha2-antiplasmin (PAP) complex, plasminogen activator inhibitor (PAI-1), fibrinogen, and tissue plasminogen activator (TPA), could also have a role in thromboembolic prediction in AF patients [17,18,19,20]. The gene discussed is SERPINE1; the disease is atrial fibrillation.